Patient Square Capital as of March 31, 2026
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 29 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 40.1 | $226M | 8.2M | 27.70 | |
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $27M | 37k | 730.25 | |
| Insmed Com Par $.01 (INSM) | 4.6 | $26M | 158k | 163.52 | |
| Beone Medicines Sponsored Ads (ONC) | 4.2 | $24M | 81k | 296.97 | |
| Cogent Biosciences (COGT) | 4.1 | $23M | 596k | 38.49 | |
| Mirum Pharmaceuticals (MIRM) | 3.8 | $21M | 230k | 92.38 | |
| Belite Bio Sponsored Ads (BLTE) | 3.3 | $19M | 117k | 159.44 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.2 | $18M | 990k | 18.09 | |
| Nektar Therapeutics Com New (NKTR) | 2.7 | $15M | 210k | 71.95 | |
| Dbv Technologies S A Sponsored Ads (DBVT) | 2.6 | $15M | 694k | 20.89 | |
| Pharvaris N V (PHVS) | 2.5 | $14M | 493k | 28.25 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.4 | $14M | 121k | 111.35 | |
| Xenon Pharmaceuticals (XENE) | 2.3 | $13M | 227k | 58.15 | |
| Celcuity (CELC) | 1.9 | $11M | 95k | 114.14 | |
| Eyepoint Com New (EYPT) | 1.8 | $10M | 795k | 12.89 | |
| Merck & Co (MRK) | 1.7 | $9.6M | 80k | 120.29 | |
| Arcutis Biotherapeutics (ARQT) | 1.7 | $9.4M | 401k | 23.56 | |
| Allogene Therapeutics (ALLO) | 1.5 | $8.4M | 3.5M | 2.44 | |
| Kymera Therapeutics (KYMR) | 1.5 | $8.3M | 100k | 83.29 | |
| Dianthus Therapeutics (DNTH) | 1.4 | $7.9M | 94k | 83.92 | |
| Enliven Therapeutics (ELVN) | 1.4 | $7.8M | 200k | 39.20 | |
| Perspective Therapeutics Com New (CATX) | 1.2 | $6.8M | 1.6M | 4.17 | |
| Definium Therapeutics Com Shs (DFTX) | 1.1 | $6.3M | 331k | 18.90 | |
| Harrow Health (HROW) | 1.0 | $5.8M | 165k | 35.26 | |
| Protara Therapeutics Com Stk (TARA) | 1.0 | $5.4M | 1.0M | 5.21 | |
| Cytomx Therapeutics (CTMX) | 0.9 | $5.1M | 1.1M | 4.70 | |
| Arcus Biosciences Incorporated (RCUS) | 0.7 | $4.2M | 195k | 21.60 | |
| Assembly Biosciences Com New (ASMB) | 0.7 | $3.8M | 136k | 27.75 | |
| Spyre Therapeutics Com New (SYRE) | 0.0 | $50k | 1.0k | 50.44 |
